How we verified this list
Every fact about every firm below came off that firm's own website, fetched in September 2026. Where a firm does not publish something, the profile says "Not published" rather than guessing. Where a firm does not publish a fact on its own site, the profile says so explicitly. Four filters decided who made it.
The four inclusion filters
1. A Boston-metro address, published on the firm's own site. Headquartered in Boston itself, or in a town inside the Boston-Cambridge-Newton, MA-NH metropolitan area, roughly 20-25 miles out. Burlington and Waltham both qualify; the "Which Boston advisor fits my deal?" section explains why.
2. Sell-side capability for a private company. A firm that only advises buyers, or only runs financing, does not help a founder sell. Business brokers are included as their own labeled, honest tier below the core list, not blended into it.
3. Published sector or deal-size evidence. A named transaction with a date, a published enterprise-value range, or a firm-level track-record number the firm puts its own name to. One of the three, minimum.
4. A checkable identity. Named leadership, a named legal entity, or both. Anonymous firms are not on this page.
Cross-referenced against: the ProCloser Tech M&A Deal Index (1,740 tracked 2026 acquisitions), the Greater Boston Chamber of Commerce's published description of the region's key industries, and MassBio's published member count for the life sciences cluster. No firm paid for placement, and no firm reviewed its own entry before publication.
What we excluded, and why. Several firms that other Boston "best M&A advisor" content names were left off this page because we could not independently verify a staffed Boston-metro office, or even a single named local banker, from the firm's own site as of September 2026. Houlihan Lokey, which industry sources describe as having a Boston office, is the clearest example: we could not confirm a staffed Boston office on the firm's own website. A second national bank often cited for Boston technology coverage did not confirm a Boston office on its own site either, and secondhand reporting is not the bar this page holds firms to, so it is not on this list either. Names that don't survive that bar aren't listed, whatever their reputation elsewhere.
The national business-broker franchise networks Sunbelt and Transworld are a related but separate case. Both operate in the Boston area, but we could not confirm a current local address, named local broker or deal-size range for either one on the networks' own websites as of September 2026. Rather than publish an unverified address, we left both off the ranked list entirely; they are named only in the step-down tier below as network brands, with the recommendation to confirm a specific local office on the network's own locator.
Our credential. ProCloser runs a public technology M&A deal index covering 1,740 tracked 2026 acquisitions, each with a source link. A text search of every deal's target, acquirer, summary and source-title fields for "Boston," "Massachusetts," named Greater Boston suburbs and sector keywords found 4 Boston-metro target companies in the entire 2026 index. We use that finding for market structure below, in the deal data section, not to rank advisors, because zero of the four named a sell-side advisor at all.
Quick comparison table
All 12 firms, before the profiles. Deal size is what the firm publishes, or "Not published" where it does not. Registration is what the firm discloses on its own site, or general public-market status where the firm itself is publicly traded.
| Firm | Deal size (EV) | Sectors | Fee model | Registration | Best for |
|---|---|---|---|---|---|
| 1. Capstone Partners | Not published; "Top 10 U.S. MMIB" | 12 groups incl. FinTech, Healthcare, TMT, Industrials | Not published | Subsidiary of Huntington Bancshares (NASDAQ: HBAN) | Broadest platform, bank-owned scale |
| 2. Mirus Capital Advisors | Not published; $3.2B/5yr across 450+ deals since 1987 | Technology, Industrial, Business Services, Healthcare & Life Sciences, Consumer | Not published | Not published on the firm's site | Longest-running Boston-metro generalist |
| 3. Covington Associates | Not published; $6B+ across 300+ deals since 1991 | Healthcare, Business Services, Consumer & Industrial, Technology | Not published | Not published on the firm's site | Established downtown Boston boutique |
| 4. BellMark Partners | Not published; team has closed 400+ deals collectively | Business Services, Consumer, Industrials, Healthcare | Not published | Not published on the firm's site | Two-city, senior-only boutique |
| 5. Shields & Company | Not published | Business Services, Consumer/Food & Beverage, Healthcare & Human Services, Niche Manufacturing, Specialty Distribution | Not published | Not published on the firm's site | Family-owned middle-market sellers |
| 6. 733Park | $5M-$350M, published | Payments, fintech, vertical SaaS, AI-native | Not published | Not published on the firm's site | Payments and ISO sellers |
| 7. AGC Partners | Not published; 585+ deals since 2003 | Enterprise software, AI, cybersecurity, fintech, healthcare IT | Not published | Not published on the firm's site | Technology-only sellers wanting deal volume |
| 8. Provident Healthcare Partners | Not published | Healthcare services: physician practices, home health, specialty pharmacy | Not published | Not published on the firm's site | Healthcare services businesses |
| 9. Back Bay Life Science Advisors | $10M-$500M, published | Biopharma, medtech, diagnostics, life-science tools, digital health | Not published | Not published on the firm's site | Science-heavy life sciences sellers |
| 10. Outcome Capital | Not published | Pharma/biotech, diagnostics, devices, digital health, healthcare services | Not published | Not published on the firm's site | Sale, partnering or financing decisions |
| 11. Progress Partners | Not published on its own site; third-party reporting cites $15M-$150M | AdTech, digital media, MarTech, consumer, digital health, GovCon | Not published | Not published on the firm's site | AdTech and digital media sellers |
| 12. William Blair | Not published | Application/vertical software, HR tech, digital media, e-commerce, edtech, enterprise IT, gaming | Not published | Not published on the firm's site | $150M+ technology exits |
Which Boston advisor fits my deal?
Boston's dominant industries, per the Greater Boston Chamber of Commerce's own published description of the region and MassBio's own published member count, are financial services and investment management, healthcare and life sciences, and technology, alongside professional services and advanced manufacturing. Route on sector first, and only compare firms within a sector once you know which one you're in.
| Sector / situation | Specialist(s) | The tell |
|---|---|---|
| Payments, ISOs, merchant processing, vertical SaaS, AI-native | 733Park | Founder Lane Gordon's career began in ISO and merchant-portfolio transactions; three of four named recent closes are payments deals. |
| Enterprise software, AI, cybersecurity | AGC Partners | Named No. 1 tech M&A boutique by deal volume every year 2009-2025, per its own site; technology-only since 2003. |
| Biopharma, medtech, diagnostics, life-science tools | Back Bay Life Science Advisors, Outcome Capital | Bankers with MD/PhD/physician backgrounds; Back Bay publishes a $10M-$500M range. |
| Healthcare services: physician practices, home health, specialty pharmacy | Provident Healthcare Partners | Boston HQ since 1998, healthcare-only mandate, no product or device work. |
| AdTech, digital media, MarTech | Progress Partners | A live, dated 2025-2026 deal list including CustomWeather and AgileFleet, named on the firm's own site. |
| Generalist industrials, business services, consumer, niche manufacturing | Mirus Capital Advisors, Covington Associates, Shields & Company, BellMark Partners | Decades of Boston-metro deal history in sectors with no dedicated specialist on this page. |
| Broadest platform, largest Boston-based bank | Capstone Partners | 12 published industry groups; owned by a public bank holding company (Huntington Bancshares). |
| $150M+ technology and services exits | William Blair | A national platform with a genuine, verified Boston office; step up here once you're past the lower middle market. |
| Main Street, under roughly $3M revenue | A national broker franchise network such as Sunbelt or Transworld | Brokers, not bankers. Confirm the specific local office on the network's own locator. Right tool below this size, wrong tool above it. |
Selling a Boston-Area Business? Get Matched Free.
ProCloser.ai matches Boston-metro business owners with vetted M&A advisory firms based on your sector, deal size and buyer type. Includes success-only options. No retainer required to get matched.
Get Matched with a Boston M&A Advisor →Boston's lower middle market generalists ($2M-$100M+ EV)
These five firms don't specialize in one industry. They're the right first call if your company doesn't fit one of the sector specialists below, roughly $2M to $100M in enterprise value, and you want a firm with genuine Boston-metro deal history.
1Capstone Partners
| Headquarters | 10 Post Office Square, Suite 800N, Boston, MA 02109, confirmed on the firm's own contact page, with an additional office in Denver and others across the country |
| Founded | Not published on the firm's site |
| Team | CEO John Ferrara, named on the firm's own site. Full leadership roster not published on the firm's site. |
| Deal size | Not published as a fixed band. The firm describes itself as "among the largest and most active investment banking firms in the United States" and a "Top 10 U.S. MMIB" (middle market investment bank). |
| Sectors | 12 published industry groups: Aerospace, Defense, Government & Security; Agriculture; Building Products & Construction Services; Business Services; Consumer & Retail; Energy, Power & Infrastructure; FinTech & Services; Healthcare; Industrial Technology; Industrials; Technology, Media & Telecom; Transportation & Logistics. |
| Track record | A subsidiary of Huntington Bancshares Incorporated (NASDAQ: HBAN). Recently acquired TM Capital from Janney Montgomery Scott, which the firm says "solidif[ies] its position as a Top 10 U.S. MMIB." |
Capstone is the largest homegrown platform on this list, and the only one owned by a publicly traded bank holding company. That ownership shows up in the breadth of its published coverage, 12 industry groups spanning everything from agriculture to aerospace, rather than in a single specialty. For a Boston founder who wants one call that can plausibly cover almost any sector, this is the firm.
The named transactions we pulled from the firm's own transactions page, Wilbar Group's sale to StoneTree Investment Partners, Shannon Chemical Corporation's sale to Usalco, Tetrasolv's sale to Integrated Water Services, and Secure Bancard's sale to an undisclosed strategic buyer, span building products, chemicals, water infrastructure and fintech. None of the four we could pull named a Boston or Massachusetts-headquartered target, which is a fair reflection of a national platform rather than a hyper-local one.
Recent closes: Wilbar Group to StoneTree Investment Partners (Building Products & Construction Services); Shannon Chemical Corporation to Usalco; Tetrasolv to Integrated Water Services; Secure Bancard to an undisclosed strategic buyer.
Best for: Boston-based sellers who want the broadest published industry coverage and bank-scale resources without leaving the city, especially in sectors that don't have a dedicated specialist on this page.
Considerations: being a Top 10 national MMIB and a subsidiary of a large bank holding company cuts both ways. You get scale and cross-sector reach; you may not get the founder-level attention a $2M-$15M revenue seller gets from a smaller boutique. The pages we pulled did not publish a deal-size floor, so ask directly whether your specific revenue size gets a Managing Director or an associate leading the process.
2Mirus Capital Advisors
| Headquarters | 200 Summit Drive, 4th Floor South, Burlington, MA 01803, about 15 miles northwest of downtown Boston, confirmed on the firm's own site (merger.com) |
| Founded | 1987. The firm's own site describes "35+ years of experience" and "four decades of excellence." |
| Team | Doug Stebbins and Roger Christopher, Managing Directors, named on the firm's own site; Christopher covers Healthcare & Life Sciences and Technology. 17 senior bankers on staff overall. Full roster not published on the firm's site. |
| Deal size | Not published as a hard band; $3.2 billion in cumulative transaction value over the past five years across 450+ completed transactions since 1987 implies a typical deal size consistent with the lower middle market. |
| Sectors | Technology, Industrial, Business Services, Healthcare & Life Sciences, Consumer. |
| Track record | 450+ completed transactions since 1987; 50+ sell-side M&A transactions in the past five years; joined GCG, part of the 570-member GGI global network, in 2019, and expanded to Chicago the same year. |
Mirus is the longest-running independent shop on this list, and the only one headquartered in a Boston suburb rather than downtown. Thirty-five-plus years and 450-plus closed deals is a real, verifiable operating history, not a marketing claim, and the firm's named 2025-2026 closes span software, medical imaging and industrial photonics.
The firm's own site names Daymark Solutions' sale to ePlus, Oxipit's sale to Sectra, RAM Photonics' sale to TE Connectivity, and Boston Green Company's recapitalization with Fort Point Capital as recent transactions. Daymark is itself one of the four Boston-metro target companies we found independently in the ProCloser Deal Index, discussed in the deal data section below, which is a useful cross-check: an advisor's own claimed deal and our independently sourced deal data line up.
Recent closes: Daymark Solutions to ePlus; Oxipit to Sectra; RAM Photonics to TE Connectivity; Boston Green Company recapitalization with Fort Point Capital.
Best for: Boston-metro founders across technology, industrial, business services, healthcare and consumer who want one of the region's longest-running independent shops and a firm with hundreds of closed deals of reference.
Considerations: Mirus is Burlington-based, not downtown Boston, which matters if you specifically want boots on the ground near the Financial District. The firm's own pages don't publish a deal-size floor or ceiling, so confirm their typical enterprise value range for your sector before assuming lower middle market fit.
3Covington Associates
| Headquarters | 99 Summer Street, Suite 200, Boston, MA 02110, confirmed on the firm's own site |
| Founded | 1991, by Chris Covington, who has over 40 years of M&A and investment banking experience per the firm's own site |
| Team | Chris Covington (Founder); Managing Directors Tom Cibotti, Ben Dunn, Scott Fisher, Grant Grava, Andrew Johnson, Tim McMahon, Chris Tashjian and James Vandervelden; Director Sean Rondeau; Director of Finance Sandra Deveau; Vice Presidents Perry De Fazio, John Lucey and Alexander Ross. |
| Deal size | Not published as a hard band; more than 300 transactions totaling over $6 billion for private and publicly traded companies since inception spans both small and large mandates. |
| Sectors | Healthcare, Business Services, Consumer & Industrial, Technology. |
| Track record | More than 300 transactions since 1991, totaling over $6 billion in value. |
Covington is the second-oldest firm on this list and carries the deepest named leadership bench, eight Managing Directors plus supporting Directors and Vice Presidents, all on the firm's own team page. That's a large boutique by lower-middle-market standards.
The named track record we could verify from the pages we pulled, the $1.3 billion sale of Inverness Medical Technology to Johnson & Johnson, the $1.8 billion acquisition of Biosite, and roughly 30 transactions totaling over $6 billion in value with Inverness Medical Innovations, is real but decades old. It shows the firm can execute complex, large healthcare and medtech deals; it doesn't by itself tell you what a current, smaller mandate looks like.
Recent closes: the firm's site named the $1.3 billion sale of Inverness Medical Technology to Johnson & Johnson and the $1.8 billion acquisition of Biosite as the firm's most prominent reference deals; a separate, more current transactions archive exists on the firm's site but was not pulled in full as of September 2026.
Best for: founders who want a firm with more than three decades of Boston presence and a stable, eight-person Managing Director bench, especially in healthcare and diversified middle-market sectors.
Considerations: the named deals we could verify are decades old. Ask Covington directly for closed deals from the last 24 months in your specific sector and size range before assuming their historic marquee deals reflect current, smaller-mandate capacity.
4BellMark Partners
| Headquarters | 75 Central Street, 2nd Floor, Boston, MA 02109, confirmed on the firm's own site, with a second office at 25101 Chagrin Blvd, Suite 210, Beachwood, OH 44122 |
| Founded | 2009 |
| Team | Senior investment bankers each with more than 25 years of experience, per the firm's own site; individual names not published on the firm's site. |
| Deal size | Not published as a hard band; the firm describes serving "middle market companies" including "middle market and lower middle market companies." |
| Sectors | Business Services, Consumer, Industrials, Healthcare. |
| Track record | The senior team's collective experience spans more than 400 closed transactions, per the firm's own site. |
BellMark is the smallest firm by published headcount on this list, and it markets that as a feature: senior-only staffing across two cities, Boston and Cleveland, rather than a large associate-driven team. The firm serves family businesses, entrepreneurial or closely-held companies, private equity-owned companies, and small-cap public companies.
We could not verify named, dated recent transactions from the pages we pulled as of September 2026; the firm publishes a separate Transactions page that was not fetched in full. That's a real gap in what we could confirm, not a claim that the firm lacks a deal history, its own site cites the 400-plus collective closed-transaction figure for its senior team.
Recent closes: Not detailed on the firm's site.
Best for: founder-owned, PE-backed or small-cap public companies in business services, consumer, industrials or healthcare who want a two-city boutique with senior-only staffing.
Considerations: we could not verify named recent transactions from BellMark's own site as of September 2026, so ask for three closed references from the past 24 months before engaging.
5Shields & Company
| Headquarters | 800 South Street, Waltham, MA 02453, confirmed on the firm's own site, about 10 miles west of downtown Boston |
| Founded | Not published on the firm's site |
| Team | Kevin Jolley appears as a named contributor on the firm's site; a full team roster is published separately at shieldsco.com/meet-the-team, not pulled in full as of September 2026. |
| Deal size | Not published on the firm's site; the firm describes itself as focused on "family-owned and privately-held middle-market businesses." |
| Sectors | Business Services, Consumer/Food & Beverage, Healthcare & Human Services, Industrial Products & Services, Niche Manufacturing, Specialty Distribution. |
| Track record | Named transactions on the firm's own site: Functional Coatings' sale to tesa tape, Ferguson Perforating's sale to Reliance Steel & Aluminum, McCue Corporation's partnership with Eureka Growth Capital, Hub Pen's partnership with Tenex Capital Management, Explorica's acquisition by WorldStrides, and Dodge Company's sale to Matthews International in June 2025. |
Shields has the most varied named deal list of any generalist on this page: coatings, metals distribution, promotional products, corporate travel and mortuary supplies all appear as closed transactions on the firm's own site. That range is a reasonable proxy for a true generalist mandate.
The most recently dated deal we could confirm, Dodge Company's sale to Matthews International, closed in June 2025, which is current enough to matter. The other named deals didn't carry dates on the pages we pulled.
Recent closes: Dodge Company to Matthews International, June 2025; Functional Coatings to tesa tape; Ferguson Perforating to Reliance Steel & Aluminum; McCue Corporation partnership with Eureka Growth Capital; Hub Pen partnership with Tenex Capital Management; Explorica acquired by WorldStrides.
Best for: family-owned and privately-held middle-market businesses in niche manufacturing, specialty distribution or consumer/food and beverage who want a Waltham-based firm with a diverse, dated deal list.
Considerations: founding year and a hard deal-size band are not published on the firm's site, so confirm both directly, especially if your revenue sits at the smaller end of the lower middle market.
Boston's sector specialists
These six firms each stake their identity on one sector: payments and fintech, enterprise technology, healthcare services, life sciences, or adtech and digital media. If your company fits one of these categories, start here before calling a generalist.
6733Park
| Headquarters | One Boston Place, Suite 2600, Boston, MA 02108, confirmed on the firm's own site |
| Founded | 2006 |
| Team | Lane Gordon, Principal, whose published bio describes a 25-year M&A career that began in merchant portfolio and ISO transactions. |
| Deal size | $5 million to $350 million in enterprise value, published on the firm's own site. |
| Sectors | Payments and payment processing, fintech, vertical SaaS, AI-native companies. |
| Track record | $10+ billion in transaction volume facilitated; 200+ deals closed; 25+ years of collective M&A expertise; a typical timeline of four to six months from engagement to close, all per the firm's own site. |
733Park is the clearest single-sector specialist on this list. Its founder's career started in exactly the niche the firm now serves, merchant portfolios and ISO transactions, and that specificity shows up directly in the named 2024-2025 deals: ProSites' acquisition of GeniusVets, Avalara's acquisition of Hopscotch, Unity Fi Solutions' acquisition of a merchant portfolio from Forefront, and Alipse Payments' acquisition of ReliantPay.
The firm also publishes vertical SaaS and AI-native companies as covered sectors, so it isn't strictly a payments-only shop, but three of the four named closes we could verify are payments or merchant-processing deals. A pure vertical-SaaS seller with no payments angle should ask directly for closed references outside payments before assuming the fit is as strong as it is for a payments company.
Recent closes: ProSites' acquisition of GeniusVets (2025); Avalara's acquisition of Hopscotch (2024); Unity Fi Solutions' acquisition of a merchant portfolio from Forefront (2025); Alipse Payments' acquisition of ReliantPay (2024).
Best for: payments, ISO and merchant-processing sellers, plus vertical SaaS and AI-native companies, in the $5M-$350M enterprise value range, who want a firm whose founder's career started in exactly this niche.
Considerations: the published deal list leans heavily payments and fintech. If your company is vertical SaaS or AI-native but has nothing to do with payments, ask 733Park directly for closed references in your specific vertical rather than assuming the payments track record transfers.
7AGC Partners
| Headquarters | 99 High Street, 28th Floor, Boston, MA 02110, confirmed on the firm's own site, with additional offices in New York, London, Silicon Valley, Los Angeles, Minneapolis, Denver and Chicago |
| Founded | 2003 |
| Team | Co-founders Benjamin Howe (CEO) and Maria Lewis Kussmaul (Partner); Jon Guido, COO and Partner; Partners Eric Davis, Fred Joseph, Dennis Rourke, Charlie Schopp, Jonathan Weibrecht and Russ Workman; Tristan Hanley, Principal. All named leaders are based in the Boston office, per the firm's own team page. |
| Deal size | Not published as a fixed band; the firm's client base is described as "middle market" and "emerging growth" technology companies. |
| Sectors | Enterprise software, artificial intelligence, cybersecurity, fintech and healthcare IT, within a technology-only mandate. |
| Track record | Over 585 transactions since inception; named the No. 1 technology M&A boutique by deal volume every year from 2009 through 2025, per the firm's own site; 60+ team members across 9 global offices including Boston, London and New York; 28 technology deals closed in 2025 and 20 new engagements signed in 2026 year to date. |
AGC Partners is the most singularly focused technology bank on this list: 585-plus deals, all technology, over 23 years, with a leadership team that's been at the firm since its founding and is publicly named on its own site. That kind of stability and specialization is rare at this size.
The named 2025-2026 closes span a wide range of technology sub-sectors: Buildium and Panzura (growth equity), RoomPriceGenie and Certify (M&A), Exostar's divestiture to Thoma Bravo, Qmetry's acquisition by SmartBear, Chaos's acquisition by Enscape, Klevu's acquisition by Searchspring, and Reposify's acquisition by CrowdStrike. That breadth across software categories, rather than one narrow vertical, is consistent with a firm that competes on volume and technology-only focus rather than a single niche.
Recent closes: Buildium (growth equity); RoomPriceGenie (M&A); Exostar's divestiture to Thoma Bravo; Loxo (growth equity); Certify (M&A); Qmetry's acquisition by SmartBear; Chaos's acquisition by Enscape; Klevu's acquisition by Searchspring; Panzura (growth equity); Reposify's acquisition by CrowdStrike.
Best for: technology-only sellers, especially enterprise software, AI, cybersecurity and fintech companies, who want the single most active tech M&A boutique by published deal count and a leadership team headquartered in Boston.
Considerations: AGC's volume claim, No. 1 by deal count for 16 straight years, is about breadth across many deal sizes, not a guarantee of senior attention on any one specific small mandate. With 9 global offices and a 60-person team, ask which specific partner would run your process and how many of that partner's last 10 closes were in your size range.
8Provident Healthcare Partners
| Headquarters | One Financial Center, Boston, MA 02111, confirmed on the firm's own site, with additional offices in Minneapolis, MN and New York, NY |
| Founded | 1998, by Robert Ciardi |
| Team | Individual leadership names not published on the firm's homepage; the firm's team page lists current leadership. |
| Deal size | Not published on the firm's site. |
| Sectors | Healthcare investment banking for privately held companies, with a described focus on physician practices, home health, specialty pharmacy and related healthcare services businesses. |
| Track record | "Over two decades" of healthcare investment banking services, per the firm's own site. |
Provident is the healthcare-services specialist on this list, distinct from the life-sciences product specialists below. Its focus is businesses that deliver care or pharmacy services, physician practices, home health agencies, specialty pharmacy operators, rather than companies developing a drug or device.
We could not verify named, dated 2026 transactions from the pages we pulled as of September 2026. The firm's own site references a Transactions section in its navigation that was not fetched in full, so this profile is thinner on specifics than we'd like, and we're saying so rather than filling the gap.
Recent closes: Not detailed on the firm's site.
Best for: healthcare services businesses, physician practices, home health, specialty pharmacy, based in or selling into the Boston healthcare ecosystem.
Considerations: we could not verify named 2026 transactions from the pages we pulled as of September 2026, so ask Provident directly for three recent closed references in your specific healthcare services sub-sector.
9Back Bay Life Science Advisors
| Headquarters | 545 Boylston Street, 12th Floor, Boston, MA 02116 (Back Bay), confirmed on the firm's own site, with an additional office in Toronto |
| Founded | 2010 |
| Team | Individual leadership names not published on the firm's site; the firm describes its people as scientific researchers, biotech executives, physicians, surgeons, bankers and data researchers. |
| Deal size | $10 million to $500 million, published on the firm's own site. |
| Sectors | Biopharma, medtech, diagnostics, life-science tools and digital health, combining strategy consulting with investment banking execution. |
| Track record | "Hundreds of successful strategy projects and transactions" over 13 years of operation, per the firm's own site. Entered a strategic partnership with DNB Bank in 2023 to combine capital-markets capability with scientific consulting. |
Back Bay is built around a specific bet: that a life sciences deal goes better when the banker can also read the science. Its team blends MDs, PhDs, physicians and surgeons with bankers, and it pairs that with a published $10M-$500M range, wide enough to cover most lower-middle-market and middle-market life sciences companies.
The firm counts strategy consulting projects and transactions together in its published "hundreds of successful" claim, which is a meaningfully different mix than a pure M&A boutique. That's not a red flag, life sciences deals often need both, but it means the raw project count overstates pure sale-side deal volume.
Recent closes: not individually named on the firm's site.
Best for: biopharma, medtech and diagnostics companies that need a banker who can also speak the science, in the $10M-$500M range.
Considerations: ask specifically how many of the firm's "transactions" (as opposed to strategy projects) closed in the past two years, since the two service lines are counted together in its published claims, and confirm which named team member would lead your specific deal.
10Outcome Capital
| Headquarters | 20 Custom House Street, Suite 1200, Boston, MA 02110, confirmed on the firm's own site |
| Founded | Not published on the firm's site; the firm was previously named WWC Securities and rebranded to Outcome Capital after launching a Boston-based life sciences practice, per its own site. |
| Team | Individual names not fully published on the firm's site, beyond a client testimonial referencing "Arnie and Oded." |
| Deal size | Not published on the firm's site. |
| Sectors | Pharma/biotech, diagnostics, medical devices, life science tools and research, digital health, healthcare services, telemedicine and remote patient monitoring. |
| Track record | Global reach described as extending from Boston to Washington D.C. to London. Named "Top Life Sciences Advisory and Strategic Investment Banking Solutions 2026" by Life Sciences Review. |
Outcome Capital covers the widest range of life-sciences and healthcare-adjacent sub-sectors of any specialist on this list, from pharma and diagnostics to telemedicine and remote patient monitoring, and it explicitly serves M&A, partnering and corporate finance as three overlapping paths rather than treating a sale as the only outcome.
That breadth is a strength for a company unsure which path fits, and a weakness if you already know you want a clean, competitive sale process and are comparing focus against Back Bay Life Science Advisors specifically. We could not verify named, dated transactions from the pages we pulled as of September 2026.
Recent closes: not individually named on the firm's site.
Best for: life sciences and digital health companies that want a Boston-based, sector-only bank with a heavier emphasis on partnering and corporate finance alongside M&A.
Considerations: founding year, named leadership and dated recent closes were not on the pages we pulled as of September 2026. Ask for those directly, and clarify what share of Outcome's work is outright sale versus licensing, partnering or financing, since the firm's own language covers all four.
11Progress Partners
Deal Index: credited as buy-side advisor on 1 tracked 2026 tech deal (as of Sep 2026)
| Headquarters | 10 Winthrop Square, 6th Floor, Boston, MA 02110, confirmed on the firm's own site, with additional offices in New York, NY and McLean, VA |
| Founded | Not independently confirmed on the firm's site as of September 2026; the site notes "over 20 years" of M&A experience. |
| Team | Named in testimonials on the firm's own site but without full titles in the content we pulled: Parag, Bret, Tim and Tim Harned. |
| Deal size | Not published as a fixed band on the firm's site. |
| Sectors | Consumer Goods & Services, Digital Health & Wellness, Retail & Commerce, AdTech, SaaS & Services, GovCon & Defense, MediaTech. |
| Track record | "Billions of dollars transacted across hundreds of deals," per the firm's own site. |
Progress Partners is the most current specialist on this list by named deal dates: its own site lists a September 2026 close, and the ProCloser Deal Index independently credits the firm as buy-side advisor on Moonshot Partners' acquisition of CustomWeather, also announced in September 2026. That's a rare instance on this page of a firm's own claim and our independent deal-index tracking lining up on the same transaction.
The firm covers adtech and digital media most distinctively among Boston specialists, alongside consumer, digital health, GovCon and MediaTech, sectors underrepresented elsewhere on this list.
Recent closes: Moonshot Partners' acquisition of CustomWeather, September 2026; MP Wired for HR's sale to OneDigital, April 2026; Rocket Lab's acquisition by MiQ, April 2026; TrueData's sale to ID5, November 2025; AgileFleet's acquisition by Banyan Software, June 2025.
Best for: AdTech, digital media and MarTech companies, plus consumer and digital-health businesses, that want a Boston-founded boutique with a current 2026 deal list.
Considerations: Progress Partners also runs New York and McLean, VA offices, so ask specifically which office and which banker would staff a Boston-area mandate.
Not Sure Which Boston M&A Advisor Fits Your Deal?
Tell us your sector, revenue range and buyer type priority. ProCloser.ai will recommend 2-3 advisors from this list that match your specific Boston-area business. Free, no obligation.
Get Personalized Recommendations →What 2026 deal data shows for Boston-area companies
The ProCloser Deal Index tracks 1,740 tech and technology-adjacent acquisitions announced in 2026, each with a source link. We searched every deal's target, acquirer, summary and source-title text for "Boston," "Massachusetts," named Greater Boston suburbs and place names. Here's the honest result: 4 Boston-metro target companies turned up in the entire index, and zero named a publicly credited sell-side advisor. That's the sample size, stated plainly rather than dressed up.
Across all sectors and geographies
Via text search of target, acquirer and summary fields
All four were undisclosed-terms deals
The four deals, in order of announcement:
- Daymark Solutions (a "Massachusetts-based IT solutions and professional services provider," per the acquirer's own press release) was acquired by ePlus inc., announced August 24, 2026, terms undisclosed, no advisor named on either side.
- Nara Logics (a "Boston-based explainable AI decision-intelligence company serving federal national security customers," per the acquirer's own press release) was acquired by OMNI, announced June 2, 2026, terms undisclosed, no advisor named.
- IOvations (a "Burlington, Massachusetts-based cybersecurity solutions provider," per the acquirer's own press release) was acquired by Alchemy Technology Group, announced April 23, 2026, terms undisclosed, no advisor named.
- BHE Consulting (a "Boston-based Sage and Acumatica ERP solutions provider," per the acquirer's own press release) was acquired by Net at Work, announced January 26, 2026, terms undisclosed, no advisor named.
A fifth, related data point: Progress Software, headquartered in Burlington, MA and publicly traded as PRGS, appears in our index as an acquirer rather than a target, paying $400 million in cash for Domo's AI and data platform business, announced July 22, 2026. That deal did name advisors, Jefferies for Domo (sell-side) and Citi for Progress Software (buy-side), per Progress Software's own SEC filing, but neither is a Boston-metro firm. Even the region's one nine-figure, fully advised 2026 deal we found routed to national banks, not local boutiques, which is a fair illustration of how the largest, most complex mandates behave differently from the founder-led sales this page is mostly written for.
What this does and doesn't tell you. Use these four deals for market structure: the kinds of Boston-area companies getting acquired in 2026 include IT and managed services, AI decision-intelligence for government, cybersecurity, and ERP consulting, a reasonable cross-section of the region's technology and professional-services base. Don't use the zero-advisors-credited finding as evidence that Boston sellers skip advisors. Press releases name an advisor when a public company, a regulated buyer or a large sponsor requires disclosure, and stay silent otherwise; all four of our deals were undisclosed-terms transactions with private strategic buyers, exactly the profile least likely to name an advisor whether or not one was used.
The honest tier above this band
Once your enterprise value moves past roughly $150M, or your board specifically wants a national platform with public-market-caliber process discipline, this firm has a genuine, verified Boston office and belongs in the conversation. It is not, generally, the right call below that size. We looked at other bulge-bracket and mid-market banks often described as having a Boston presence and could not independently verify a staffed local office from their own sites as of September 2026, so this tier has one firm rather than several; a name is here because we could confirm it, not because the tier is meant to be short.
12William Blair
Deal Index: credited on 5 tracked 2026 tech deals · view record (as of Sep 2026)
| Boston office | 125 High Street, Oliver Street Tower, Suite 1901, Boston, MA 02110, confirmed on the firm's own locations page |
| Founded | William Blair overall is a long-established Chicago-founded investment bank; a founding year for the Boston office specifically is not published on the firm's site. |
| Team | Individual Boston-based bankers not named on the firm's site as of September 2026. |
| Deal size | Not published on the firm's site; the firm's technology practice generally operates at the middle market and above. |
| Sectors | A broad technology practice per the firm's own technology practice page: application and vertical software, benefits and HR technology, digital media and marketing technology, e-commerce, education technology, enterprise IT, gaming and more. |
| Track record | The Boston office is described on the firm's own site as advising technology clients and working across William Blair's global investment banking platform to deepen client relationships and advance the firm's technology sector coverage. |
William Blair's Boston office is real and confirmed on the firm's own locations page, and its technology practice covers a wide range of software sub-sectors. In our own Deal Index, the firm is credited on 5 tracked 2026 tech deals, one sell-side and four buy-side, spanning names including Outcomes One's sale to H.I.G. Capital, Engage Fi's sale to Uplift, and Dealerware's sale to Wavecrest Growth Partners and Radian Capital.
Best for: technology sellers whose enterprise value has moved past the lower middle market, roughly $150M and up, who want a bank with public-market-caliber process discipline and a genuine Boston office rather than a fly-in team.
Considerations: this is the honest tier above the core list. William Blair is not typically the right call for a $5M-$40M revenue seller; its own coverage and the deal-index credits above skew toward larger, more complex mandates than the generalists and specialists above.
The honest tier below this band
Below roughly $3M in revenue, or for an owner-operated Main Street business with an individual buyer rather than a private equity platform, a business broker is the right tool, not a compromise, and it belongs in this guide even though we are not ranking a specific local office by name.
National broker franchise networks such as Sunbelt and Transworld both operate in the Boston area. We looked for a specific local office to profile on the same terms as the firms above, a published address, a named local broker, a deal-size range, and could not confirm one on either network's own website as of September 2026, so we are not publishing an address or any other unverified detail for either one here. A business broker markets your business through a listing-style process; a lower middle market advisor runs a competitive, banked auction. For an owner-operated business under roughly $3M in revenue, especially one where an individual buyer is the likely outcome, a broker is the right tool.
Best for: owner-operated businesses under about $3M in revenue that need a broker to run a listing-style sale process rather than a competitive banked auction.
Considerations: franchise territories and local staffing shift, so confirm the specific office assigned to your address on the network's own locator before you call, rather than trusting a location or broker name republished elsewhere. And if your revenue is above roughly $3M to $5M and your likely buyer is a private equity platform rather than an individual operator, one of the advisory firms above will get you a better outcome than a broker will.
Boston valuation ladder
Boston's dominant sectors, per the Greater Boston Chamber of Commerce and MassBio, price very differently. The ranges below match the ProCloser EBITDA multiples by industry report; use the valuation benchmarks tool to see where your specific deal size and sector land.
| Sub-sector | Indicative 2026 range | Source |
|---|---|---|
| SaaS & Software | 4.0-9.0x EBITDA | ProCloser EBITDA multiples by industry |
| MSP & IT Services | 5.0-9.0x EBITDA | ProCloser EBITDA multiples by industry |
| Healthcare & Medical Practices | 4.0-7.0x EBITDA | ProCloser EBITDA multiples by industry |
| Professional Services | 3.0-5.0x SDE/EBITDA | ProCloser EBITDA multiples by industry |
| Marketing, Creative & AdTech-Adjacent Agencies | 3.0-6.0x EBITDA | ProCloser EBITDA multiples by industry |
| Fintech & Payments Infrastructure | Sub-sector-specific; see our fintech guide | ProCloser fintech M&A advisors guide |
| Biopharma, Medtech, Diagnostics (pre-profit or early-revenue) | Priced on revenue, pipeline milestones or strategic value, not a standard EBITDA multiple | Case-by-case; ask Back Bay Life Science Advisors or Outcome Capital directly |
These are indicative ranges, not a valuation of your specific business. Growth, recurring revenue, margins, customer concentration and owner dependence all move a company within its range; see the full breakdown in the EBITDA multiples by industry report or get a free estimate from the business valuation calculator.
What do these advisors charge in 2026?
Fee structures follow the standard lower-middle-market pattern: a monthly retainer, often credited against the success fee at close, plus a success fee that declines as deal size grows. None of the 12 firms above published a specific fee schedule on the firm's site, which is normal, fees get negotiated per engagement. The ranges below match the ProCloser M&A advisory fees guide.
| Deal size (EV) | Monthly retainer | Success fee | Approx. blended total |
|---|---|---|---|
| Under $10M | $5,000-$15,000 | 5-6% (often Lehman-style, declining) | 5-8% of transaction value |
| $10M-$50M | $10,000-$25,000 | 3-5% | 4-6% of transaction value |
| $50M-$150M | $15,000-$35,000 | 2-4% | 3-4% of transaction value |
| $150M+ (step-up tier) | $25,000-$75,000 | 1-2% | 1.5-3% of transaction value |
Whichever firm you choose, confirm three things before signing: whether the success fee is flat or a declining Lehman-style structure, whether the monthly retainer is fully credited against it at close, and what the minimum fee floor is if your deal ends up smaller than expected. See our full fees guide and the fee calculator to model your own deal.
The frames we use in this guide
- The Metro-Suburb Address Test. A firm in Burlington or Waltham is still "Boston" for this list if it sits inside the Boston-Cambridge-Newton metro area. Don't disqualify a real firm over a suburban zip code, and don't let a broker's marketing claim of "Boston's top" paper over the fact that a national franchise's local office may be well outside the city. Check the address, not the adjective.
- The Bank-Owned Scale Trade-off. When a Boston boutique is owned by or affiliated with a larger institution, Capstone Partners is a Huntington Bancshares subsidiary, you trade founder-level attention for balance-sheet-backed scale. Neither is wrong; ask which one you're buying before you sign.
- The Science-Fluency Premium. In life sciences specifically, a banker who can read your data package, MD/PhD-staffed, like Back Bay Life Science Advisors, closes faster than a generalist banker learning your science mid-process. Test this in the first call by asking a technical question about your own data and watching whether they follow it.
- The Broker-to-Banker Handoff Point. Roughly $3M to $5M in revenue is where a Main Street broker (a national franchise network such as Sunbelt or Transworld) stops being the right tool and a lower middle market advisor becomes worth the higher fee, because that's roughly where private equity platforms start looking instead of individual buyers.
- The Credited-Advisor Blind Spot. Our own deal index found zero credited sell-side advisors on the 4 Boston-metro target deals we tracked in 2026. That's not evidence Boston sellers skip advisors, it's evidence that undisclosed-terms deals, all 4 of ours were undisclosed, rarely name one. Don't use "no press mention" as a proxy for "no advisor was used," for your own deal or anyone else's.
How to verify an advisor is legit and unconflicted
Most boutique M&A advisory firms, including nearly every firm on this list, operate as unregistered intermediaries under the SEC's M&A broker exemption (Section 15(b)(13) of the Securities Exchange Act) rather than as FINRA-registered broker-dealers, and that's normal and legal for firms that only advise on M&A transactions and don't handle client funds or securities directly. A firm that is a registered broker-dealer will typically say so on its own site. Before you sign an engagement letter with any advisor: ask which legal entity is signing, search that entity on FINRA BrokerCheck if it claims broker-dealer registration, ask for three closed references from the last 24 months in your sector and size range with the buyer's name and year, and ask directly whether the firm or any named banker has a financial relationship with likely buyers on your list. A firm with nothing to show beyond a website and a superlative claim is the pattern to walk away from, regardless of which Boston zip code it's in.
The traps in a "best Boston M&A advisor" list
Three patterns show up across generic "best M&A advisor" content for any city, and Boston is no exception. First, treating every firm with a Boston-sounding name or a client testimonial mentioning Boston as local, without checking a published address on the firm's own site; this guide excluded firms we could not verify a Boston-metro office for. Second, ranking a decades-old marquee deal (Covington's Inverness Medical or Biosite closes, for example) as if it reflects current, smaller-mandate capacity; ask any firm with an impressive historic deal for something from the last 24 months. Third, listing a business broker alongside investment banks without labeling the difference; a broker markets a listing, a bank runs a competitive process, and conflating them sets the wrong expectation for what you're buying.
Where ProCloser fits
ProCloser is not an M&A advisor and does not run sale processes. We operate a free matching service that connects Boston-area business owners with vetted advisory firms based on sector, deal size and buyer-type fit, and we track public deal data through the ProCloser Deal Index. Some firms named on this page participate in our matching network; none paid for placement in this ranking, and this page was built the same way as every other ProCloser city and sector guide.
The bottom line
Route on sector first, size second. Payments and fintech go to 733Park. Enterprise software, AI and cybersecurity go to AGC Partners. Life sciences product companies go to Back Bay Life Science Advisors or Outcome Capital. Healthcare services go to Provident Healthcare Partners. AdTech and digital media go to Progress Partners. Everything else in the lower middle market, roughly $2M to $100M EV, goes to Capstone Partners, Mirus Capital Advisors, Covington Associates, BellMark Partners or Shields & Company. Step up to William Blair above roughly $150M. Step down to a national broker franchise network such as Sunbelt or Transworld under about $3M in revenue, and confirm the specific local office on the network's own locator before you call.